Medical/Pharmaceuticals
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
SHANGHAI, March 17, 2025 /PRNewswire/ -- Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 targeted siRNA (small interfering RNA) therapeutic for se...
2025-03-17 19:00
4249
Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies
HANGZHOU, China, March 17, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced the successful completion of a new round of financing. Heda Health Fund an...
2025-03-17 18:00
2156
Healthcare Holding Schweiz Acquires Effectum CH-Rep (Switzerland)
Healthcare Holding Schweiz AG, a leading service provider and distributor of medical devices inSwitzerland, is expanding its portfolio with the acquisition of Effectum CH-Rep AG. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. BAAR, Switzerland, March 17, 2025 /PRNewswire/ -- ...
2025-03-17 16:00
2936
Fangzhou Inc.'s H2H Smart Healthcare Platform Honored as one of Guangdong's Premier High-Tech Innovation Products
GUANGZHOU, China, March 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, today announced that its proprietary "H2H Smart Healthcare Innovation Platform" has been distinguished as a "2024Guangdong Province Premier High-Qual...
2025-03-17 15:43
1882
AIM Vaccine reported a significant reduction in losses for 2024, with several major products set to launch that are expected to drive substantial revenue growth
HONG KONG, March 17, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 17, 2025, the company's performance in 2024 showed a significant reduction in losses. Preliminary assessments indicate that the company's revenue is expecte...
2025-03-17 14:30
3974
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
HONG KONG, March 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for the first-line treatment of recurrent or metastatic nasop...
2025-03-17 11:49
2075
HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease
* Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). * Batoclimab, subcutaneous formulation, offers the potential for at-home administration, improving patient convenience and accessibility. * Phase 3 study to confirm the potential...
2025-03-17 07:59
2518
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025
Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targetingHuntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO International Congress inPrague, Czech Republic. BOSTON, March 15, 2025 /PRNewswire/ -- Skyhawk Therapeut...
2025-03-15 18:07
3418
Florbetaben (18F) Injection (Neuraceq®) Set to Launch at St. Teresa's Hospital in Hong Kong in March 2025
Innovative Imaging Solution to Enhance Alzheimer's Disease Diagnosis and Patient Care in the Region BOSTON, March 14, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be available in ...
2025-03-14 21:00
3976
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This strategic ...
2025-03-14 20:52
2962
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...
2025-03-14 16:35
4224
Accropeutics Secured $12 Million in Series B Plus Financing
* Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from existing investor Morningside Ventures, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST). * Cash runway extended into the second half of 20...
2025-03-14 16:23
2480
Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaborat...
2025-03-14 15:27
3481
Bowtie and Gleneagles Hospital Hong Kong Collaborate to Upgrade VHIS Rider to Include Histotripsy Treatment In "Bowtie & Gleneagles Hospital Wellness Package"
Swift inclusion of innovative liver tumor treatment technology, lowers barriers for Hongkongers to access advanced medical services HONG KONG, March 14, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[1], collaborates with Gleneagles Hospital Hong Kong (Gleneagles), Asia's first p...
2025-03-14 13:54
3537
VISTA Eye Specialist Enhances Cataract Surgery with Advanced Technology and Strategic Partnerships
PETALING JAYA, Malaysia, March 14, 2025 /PRNewswire/ -- Klinik Pakar Mata VISTA Eye Specialist (VISTA), awell-established name in eye care in Malaysia, continues to improve itscataract surgery services through collaborations with recognized ophthalmic technology providers such as Johnson & Johnso...
2025-03-14 08:00
2879
MATELASER Introduces X1 Performance: The Ultimate Portable High-Energy Laser Therapy System for Pain Management
MIAMI, March 13, 2025 /PRNewswire/ -- MATELASER, INC., a pioneering force in laser therapy technology, is proud to announce the launch of the X1 Performance, the portable high-energy laser therapy system, designed to meet the highest U.S. medical quality standards for pain management, sports rec...
2025-03-13 22:00
2448
Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a$110 million Series E financing led by a private equity fund of Value Partners ...
2025-03-13 21:00
3531
Amcor prices private offering of $2.2 billion of senior unsecured notes
ZURICH, March 13, 2025 /PRNewswire/ -- Amcor plc (NYSE:AMCR; ASX:AMC) ("Amcor") announced today that Amcor Flexibles North America, Inc. ("AFNA"), a wholly-owned subsidiary of Amcor, has priced a private offering (the "Offering") of guaranteed senior notes in an aggregate principal amount of$2.2 ...
2025-03-13 18:11
4054
IFPA Forum Americas 2025: "Towards More Equitable, Person-Centered Care for All People Living with Psoriatic Disease in the Americas"
On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings inEurope (2022) and Asia (2023). STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from...
2025-03-13 17:00
2865
KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area
HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-party logistics (4PL) distribution services inHong Kong, M...
2025-03-13 16:30
2856
Week's Top Stories
Most Reposted
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 310 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 289 media titles]
2026-03-02 09:00
Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 284 media titles]
2026-03-03 15:49
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
8019
